Back to Search
PATRICK TASSONE, M.D.
M.D.
Otolaryngology Physician
NPI: 1326481672IndividualAccepts Medicare
Specialties, Licenses & Credentials
Otolaryngology PhysicianPrimary
Otolaryngology
Code: 207Y00000X
2019020164(MO)
CMS Specialties
PrimaryOTOLARYNGOLOGY
Education
OHIO STATE UNIVERSITY COLLEGE OF MEDICINE
Class of 2013
Research & Publications (20)
Identification of novel antigens with induced immune response in monoclonal gammopathy of undetermined significance.
PMID 19587378·Blood·2009
8-other
In vivo activity of gemcitabine-loaded PEGylated small unilamellar liposomes against pancreatic cancer.
PMID 19263052·Cancer Chemother Pharmacol·2009
7-preclinical
Loss of BRCA1 function increases the antitumor activity of cisplatin against human breast cancer xenografts in vivo.
PMID 19333003·Cancer Biol Ther·2009
7-preclinical
Janus kinase inhibitor INCB20 has antiproliferative and apoptotic effects on human myeloma cells in vitro and in vivo.
PMID 19139110·Mol Cancer Ther·2009
7-preclinical
ENT cases seen at a local 'walk-in centre': a one year review.
PMID 18485251·J Laryngol Otol·2009
8-other
Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma.
PMID 19417213·Blood·2009
7-preclinical
Are trainees being adequately taught myringoplasty? A prospective study of Eastern Deanery otolaryngology trainees' surgical experience.
PMID 18491120·Eur Arch Otorhinolaryngol·2009
8-other
Telomerase inhibitor GRN163L inhibits myeloma cell growth in vitro and in vivo.
PMID 18449204·Leukemia·2008
7-preclinical
The oral protein-kinase C beta inhibitor enzastaurin (LY317615) suppresses signalling through the AKT pathway, inhibits proliferation and induces apoptosis in multiple myeloma cell lines.
PMID 18452078·Leuk Lymphoma·2008
8-other
Emergency treatment of haemorrhage from a tracheo-bracheocephalic artery fistula: a life-threatening complication of tracheostomy.
PMID 18460965·Eur J Emerg Med·2008
5-case
Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine + FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 Trial).
PMID 18593999·Clin Cancer Res·2008
3-trial
The IASLC Lung Cancer Staging Project: revision proposal of pleural effusion and controlateral nodule staging.
PMID 18317078·J Thorac Oncol·2008
8-other
A study of olfactory testing in patients with rhinological pathology in the ENT clinic.
PMID 18444490·Rhinology·2008
8-other
A new mutant of Arabidopsis disturbed in its roots, right-handed slanting, and gravitropism defines a gene that encodes a heat-shock factor.
PMID 18381353·J Exp Bot·2008
8-other
p38 mitogen-activated protein kinase inhibitor LY2228820 enhances bortezomib-induced cytotoxicity and inhibits osteoclastogenesis in multiple myeloma; therapeutic implications.
PMID 18397345·Br J Haematol·2008
7-preclinical
Validation of PDGFRbeta and c-Src tyrosine kinases as tumor/vessel targets in patients with multiple myeloma: preclinical efficacy of the novel, orally available inhibitor dasatinib.
PMID 18524994·Blood·2008
7-preclinical
Parapharyngeal abscess: a life-threatening complication of quinsy.
PMID 18058899·Clin Anat·2008
5-case
In vivo anti-myeloma activity and modulation of gene expression profile induced by valproic acid, a histone deacetylase inhibitor.
PMID 18986388·Br J Haematol·2008
7-preclinical
Anterior fracture dislocation of the odontoid peg in ankylosing spondylitis as a cause for rhinolalia clausa: a case study.
PMID 17466090·J Laryngol Otol·2008
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1 HOSPITAL DR
COLUMBIA, MO 65212 - Phone
- (573) 882-8445
Quick Facts
- NPI
- 1326481672
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 13
- Publications
- 20
Are you this provider?
Claim Your Profile